Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00519064
Status:
COMPLETED
Last Update Posted:
2016-12-01
First Post:
2007-08-20
Brief Title:
Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine When Administered to Adults Affected by Chronic Diseases
Sponsor:
Novartis Vaccines
Organization:
Novartis
Study Overview
Official Title:
A Phase III Randomized Controlled Observer-blind Single-center Study to Compare Immunogenicity and Safety of an Adjuvanted Inactivated Subunit Influenza Vaccine to Those of a Non-adjuvanted Inactivated Subunit Influenza Vaccine When Administered to Adults Affected by Chronic Diseases
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This phase III is designed to confirm the previous trial results evaluating the safety clinical tolerability and immunogenicity of the 2006-2007 formulation of Novartis Vaccines adjuvanted influenza vaccine and subunit influenza vaccine in adults with underlying chronic diseases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-005558-63 | None | None | None |